The premise and promise of low-intensity focused ultrasound for neuropsychiatric disorders
Low-intensity focused ultrasound (LIFU) is a noninvasive neuromodulation technique that uses acoustic energy to modulate neural activity. LIFU reaches both cortical and deep brain structures with millimeter precision, making it a candidate treatment approach for various neuropsychiatric conditions. The neuromodulatory effects of LIFU depend on the acoustic parameters of the protocol in conjunction with the underlying neurobiology of the target, though the mechanisms underlying these effects are still being characterized. Early clinical work spans depression, anxiety, substance use disorder, epilepsy, Parkinson's disease, and Alzheimer's disease, with trials that remain small and heterogeneous in target and protocol. Here we review the state of the field, covering how LIFU is delivered, the mechanisms proposed to underlie its effects, the evidence for target engagement in humans, and the clinical literature to date. In addition to investigating LIFU’s clinical efficacy, considerable foundational work remains before LIFU can be effectively deployed as a therapy. Overall, LIFU has considerable potential, but rigorous mechanistic and clinical research will be essential to define its therapeutic role.
Authors
- Brooke R. Staveland (ORCID: https://orcid.org/0000-0001-8002-2821)
- Khaled Moussawi (ORCID: https://orcid.org/0000-0001-6378-0428)
- Sierra D Brandts (ORCID: https://orcid.org/0009-0003-7283-811X)
- Emme Brooke Chen
Publication Details
- Journal
- PsyArXiv (OSF Preprints)
- Published
- 2026-11-14
- DOI
- https://doi.org/10.31234/osf.io/6ujnt
- Primary Topic
- Ultrasound and Hyperthermia Applications
- Type
- preprint